Health Insurance (1992 Pathology Services Table) Regulations (Cth)

Statutory Rules 1991 No.4421

–––––––

Health Insurance (1992 Pathology Services Table) Regulations2

I, THE GOVERNOR-GENERAL of the Commonwealth of Australia, acting with the advice of the Federal Executive Council, make the following Regulations under the Health Insurance Act 1973.

Dated 12 December 1991.

BILL HAYDEN

Governor-General

By His Excellency’s Command,

B.HOWE

Minister of State for Health, Housing and Community Services

–––––––––

Citation

1. These Regulations may be cited as the Health Insurance (1992 Pathology Services Table) Regulations.

Commencement

2. These Regulations commence on 1 February 1992.

 

Repeal

3. Statutory Rule 1991 No. 353 is repealed.

Pathology services table

4. The table of pathology services in the Schedule is prescribed for the purposes of subsection 4a (2) of the Health Insurance Act 1973.

SCHEDULE Regulation 4

TABLE OF PATHOLOGY SERVICES

RULES OF INTERPRETATION

1. (1) In this table, unless the contrary intention appears:

“patient episode” means a pathology service, or pathology services whether listed in 1 or more items, for a single patient whose need for which was determined under subsection 16a (1) of the Act on the same day, whether rendered by 1 or more approved pathology practitioners on 1 or more days;

“recognised pathologist” means a medical practitioner recognised as a specialist in pathology under a determination under subsection 61 (3) of the Act;

“the Act” means the Health Insurance Act 1973.

(2) In these Rules, a reference to a request to an approved pathology practitioner includes a reference to a request for a pathologist-determinable service to which subsection 16a (6) of the Act applies.

2. (1) If a service is described:

(a) in an item in general terms; and

(b) in another item in specific terms;

only the item that describes the service in specific terms applies to the service.

 

(2) If:

(a) a service is described in 2 or more items; and

(b) subrule (1) does not apply;

only the item that provides the lower or lowest fee for the service applies to the service.

 

3. (1) In subrule (2), “service” includes an assay, estimation and test

(2) 2 or more pathology services rendered for a patient following 2 or more requests are taken to have been rendered following a single request if:

(a) the services are listed in the same item; and

(b) the patient’s need for die services was determined under subsection 16a (1) of the Act on the same day even if they are rendered by an approved pathology practitioner on more than one day.

4. If:

(a) a pathology service to which an item of the table applies is rendered for a patient in accordance with a request; and

(b) another pathology service is rendered for the patient in accord the request; and

(c) an item of the table:

(i) applies to the other service; and

(ii) is referred to in the item mentioned in paragraph (a);

the other service is treated as if it were part of the service referred to in paragraph (a).

Example:

Dr Proctor requests an extended blood grouping test (covered by item 65019) and the test includes a basic blood grouping test (covered by item 65017). Item 65017 is referred to in item 65019. Benefit is payable under item 65019 for the extended blood grouping test but benefit is not payable separately under item 65017 for the basic blood grouping test

5. For the purposes of items 65001 to 66200 (inclusive):

(a) if pathology services of a kind referred to in item 65017, 65018, 65019 or 65020 are rendered for a patient during a period when the patient is in hospital, the item applies only to the first pathology service of that kind rendered for the patient during that period; and

(b) tests (except the tests mentioned in items 65023 and 65024) carried out on material stored from a previous patient episode in response to a later request are treated as part of that previous patient episode if the second request is made within 14 days of that previous patient episode.

6. For the purposes of items 66201 to 69200 (inclusive):

(a) if a pathology service involving the measurement of a substance in urine requires a 24 hour urine collection, or calculation of a substance/ creatinine ratio, the service is treated as including any estimation of creatinine in other fluids necessary for the calculation; and

(b) tests earned out on material stored from a previous patient episode in response to a later request are treated as part of that previous patient episode if the second request is made within 14 days of that previous patient episode.

 

7. For the purposes of items 69201 to 71000 (inclusive):

(a) “serial examinations or cultures” means examinations or cultures requested on 1 occasion whether or not:

(i) the materials are received on different days by the approved pathology practitioner, or

(ii) the examinations or cultures were requested on 1 or more request forms by the treating practitioner; and

(b) tests carried out on material stored from a previous patient episode in response to a later request are treated as part of that previous patient episode if the second request occurs within 14 days of that previous patient episode.

 

8. For the purposes of items 71001 to 72800 (inclusive):

(a) in items 71025, 71026, 71027, 71028, 71029, 71030, 71031 and 71032, the estimation of a single antibody includes qualitative and quantitative assays for that antibody; and

(b) tests carried out on material stored from a previous patient episode in response to a later request are treated as part of that previous patient episode if the second request occurs within 14 days of that previous patient episode.

9. For the purposes of items 72801 to 73040 (inclusive):

(a) “biopsy material” means all tissue received by the approved pathology practitioner from an operation, or a group of operations, performed on a patient at the same time, other than a bone marrow biopsy; and

(b) if:

(i) a pathology service that is the examination of biopsy material is rendered under any of those items; and

(ii) a further pathology service mentioned in any of those items is also rendered using that biopsy material;

those pathology services are treated as 1 pathology service.

 

10. For the purposes of items 73041 to 73280 (inclusive), “serial examinations” means examinations requested on 1 occasion whether or not:

(a) the materials are received on different days by the approved pathology practitioner; or

(b) the examinations were requested on 1 or more request forms by the treating practitioner.

11. (1) For the purposes of this rule and items 73901 to 73921 (inclusive):

“approved pathology authority has the same meaning as in Division 4a of Part IIA of the Act;

“institution” means a place (other than a hospital, a nursing home or accommodation for aged persons that is attached to a nursing home or situated within a nursing home complex) at which residential accommodation or day care is, or both residential accommodation and day care are, made available to:

(a) disadvantaged children; or

(b) juvenile offenders; or

(c) aged persons; or

(d) chronically ill psychiatric patients; or

(e) homeless persons; or

(f) unemployed persons; or

(g) persons suffering from alcoholism; or

(h) persons addicted to drugs; or

(i) physically or mentally handicapped persons.

“licensed collection centre” has the same meaning as in Part IIA of the Act;

“prescribed laboratory” means a laboratory operated by:

(a) the Commonwealth; or

(b) a State; or

(c) an authority of a State or Territory; or

(d) the Northern Territory; or

(e) the Australian Capital Territory; or

(f) an Australian tertiary education institution.

“specimen collection centre” has the same meaning as in Part IIA of the Act;

“temporary collection centre” has the same meaning as in Part IIA of the Act;

“treating practitioner” has the same meaning as in paragraph 16a (1) (a) of the Act.

(2) A service mentioned in items 73901 to 73921 (inclusive) applies to a pathology service when rendered by, or on behalf of, an approved pathology practitioner who is a recognised pathologist unless:

(a) the service is rendered upon a request made in the course of an outpatient service at a recognised hospital; or

(b) the service is rendered upon a request made for a patient who is a private patient in a recognised hospital when the request was made; or

 

(c) the pathology equipment of a recognised hospital, or prescribed laboratory, is used in rendering the service; or

(d) a member of the staff of a recognised hospital, or prescribed laboratory, participates in the service in the course of the member’s employment with the hospital or laboratory.

 

(3) A service mentioned in items 73901 to 73921 (inclusive) does not apply to a pathology service to which subsection 16A (7) of the Act applies.

(4) If one item of items 73901 to 73917 (inclusive) applies to a patient episode, none of the remainder of those items apply to that patient episode.

(5) Item 73921:

(a) applies only to the approved pathology practitioner or approved pathology authority to whom the specimen mentioned in the item was referred; and

(b) applies to a service even if any item in items 73901 to 73917 (inclusive) also applies to the service.

12. The abbreviations at the end of the table may be used to identify particular pathology services or groups of pathology services.

SCHEDULE- continued

Item	Pathology service	Fee
$
GROUP PI - HAEMATOLOGY
65001	Blood count consisting of erythrocyte count, C-reactive protein, erythrocyte sedimentation rate, blood viscosity, haematocrit, haemoglobin, platelet count, leucocyte count, reticulocyte count - one or two procedures	5.40
65003	Three or more procedures to which item 65001 applies, including any calculation or measurement of erythrocyte or other indices	7.40
65005	Examination of blood film, with or without five part differential cell count, or five part differential cell count with or without examination of blood film, and if performed, any of these additional services -Direct Coombs test, tests for heterophile antibodies, cold agglutinins, examination of blood film by special stains to demonstrate Heinz bodies, parasites or iron, or examination of a blood film with alpha-naphthyl acetate esterase, choloroacetate esterase, neutrophil alkaline phosphotase, nitro blue tetrazolium, periodic acid Schiff, Sudan Black stains, or Kleihauer test for HbF on blood film, including any services specified in item 65027	9.70
65007	Full blood examination consisting of items 65003 and 65005	16.40
65009	Erythrocytes, qualitative or quantitative assessment of haemolysis or metabolic enzymes by - erythrocyte autohaemolysis test, erythrocyte fragility test, sugar water test, erythrocyte metabolic enzyme test, heat denaturation test, isopropanol precipitation test, acid haemolysis test, and quantitation of muramidase in serum or urine - one or more procedures	22.50
65011	Tests for the diagnosis of haemoglobinopathy consisting of haemoglobin electrophoresis and two of the following - examination for HbH, quantitation of HbA2 or HbF, including any services specified in items 65001, 65003, 65005 and 65007	35.00
65013	Histopathological examination of sections of bone marrow trephine biopsy including where indicated, examination of marrow smears and any special stains and immuno-chemical techniques, including any services specified in items 65001, 65003, 65005, 65007 and 65015	108.00
65015	Bone marrow examination of aspirated material including any special stains, immuno-chemical techniques and clot sections where necessary, including any services specified in items 65001, 65003, 65005 and 65007	78.00
65017	Blood grouping, including back-grouping when performed - ABO and Rh (D antigen)	9.50
65019	Blood grouping - Rh phenotypes, Kell system, Duffy system, M and N factors or any other blood group system - one or more systems, including any services specified in item 65017	18.80

SCHEDULE- continued

Item	Pathology service	Fee
$
65021	Blood grouping, including back-grouping when performed, and examination of serum for Rh and other blood group antibodies, including identification and quantitative estimation of any antibodies detected, and including any services specified in items 65001, 65003, 65005 and 65007	35.00
65023	Compatibility testing, including all necessary grouping checks of patient and donor, examination for antibodies, identification and, if necessary, quantitative estimation of any antibodies detected and any services specified in items 65001, 65003, 65005, 65007, 65017 and 65021 including all testing performed on any one day	86.00
65025	Examination of serum for blood group antibodies including identification and, if necessary, quantitative estimation of any antibodies detected	15.60
65027	Direct Coombs test, qualitative or quantitative test for cold agglutinins, or heterophile antibodies, qualitative spectroscopic examination of blood for abnormal haemoglobins, qualitative test for red cell porphyrins and detection of metalbumin (Schumm’s test) including those services specified in items 65005 and 65007 - one or more tests	8.60
65029	Skin bleeding time, coagulation time, prothrombin time, activated partial thromboplastin time, thrombin time (including test for presence of an inhibitor and serial tests for fibrinolysis), test for factor XIII deficiency, fibrinogen, or one of - fibrinogen degradation products, fibrin monomer or D-dimer - one estimation	11.80
65031	Two estimations specified in item 65029	15.70
65033	Three estimations specified in item 65029	19.60
65035	Four or more estimations specified in item 65029	23.50
65037	Quantitative assay, by one or more techniques, of plasminogen, anti thrombin III, Protein C, Protein S, heparin co-factor II, Euglobulin clot lysis time and test for lupus anticoagulant - one estimation	23.50
65039	Four or more estimations specified in item 65037	74.00
65041	Platelet aggregation in response to ADP, collagen, 5HT, ristocetin or similar substance - one or more estimations	46.50
65043	Heparin assay, only when monitoring a patient on subcutaneous heparin or low molecular weight heparin - one or more estimations	31.00
65045	Quantitative assay of Von Willebrand’s factor antigen (factor VIA related antigen), Von Willebrand’s factor (ristocetin cofactor), factor II, factor V, factor VII, factor VIII, factor IX, factor X, factor XI, factor XII, factor XIII, Fletcher factor, Fitzgerald factor, Passovy factor - one estimation	31.00
			65047	Two estimations as specified in item 65045	44.50
65049	Three or more estimations as specified in item 65045	58.00

SCHEDULE- continued

Item	Pathology service	Fee
$
GROUP P2 - CHEMICAL
66201	Quantitative estimation in serum, plasma, urine or any other body fluid, by any method except by reagent strip with or without reflectance meter or electrophoresis of - alanine amino-transferase, albumin, alkaline phosphatase, amylase, aspartate aminotransferase, bicarbonate, bilirubin (total and any fractions), calcium (total, dialysed or ionized), chloride, cholesterol, creatine kinase, creatine kinase isoenzymes (when not performed as specified in item 66245), creatinine, fructosamine, gamma glutamyl transpeptidase, globulin, glucose, lactate dehydrogenase, lipase, lithium, magnesium, phosphate, potassium, total protein, sodium, triglycerides, urate, urea - one estimation	9.60
66203	Two estimations specified in item 66201	11.60
66205	Three estimations specified in item 66201	13.60
66207	Four estimations specified in item 66201	15.60
66209	Five estimations specified in item 66201	17.60
66211	Six or more estimations specified in item 66201	19.10
66213	Qualitative estimation by any method, except by reagent strip or dip-stick of the followingurine constituents - bilirubin, cystine (cysteine), haemoglobin, melanin (melanogen), myoglobin, porphobilinogen, porphyrins, urobilinogen or pH measurement of body fluids other than urine (excepting urine acidification test), or cryoglobulins or cryofibrinogen in plasma - one or more estimations	9.30
66217	Qualitative estimation by any method except by reagent strip or dipstick of the following faecal constituents - haemoglobin, porphyrins, reducing substances - each estimation, to a maximum of three estimations, taken on separate days	6.20
66219	Immunological detection of human haemoglobin in faeces, including any additional services specified in item 66217 - one estimation in any twenty eight day period	11.80
66223	Osmolality, estimation by osmometer, in serum or in urine - one or more estimations	23.50
66225	Quantitative estimation of blood gases including tests performed from - pO2, oxygen saturation, pCO2, bicarbonate, pH, and any other measurement (eg. haemoglobin, potassium) or calculation performed on the same specimen _ one or more estimations on one specimen	32.00
66227	Estimation of blood gases as specified in item 66225 on each specimen in excess of 1 to a maximum of 6 specimens within any one day	8.40
66229	Calculus, analysis of one or more	29.00

SCHEDULE- continued

Item	Pathology service	Fee
$
66231	Drug or chemical assays - including all qualitative and quantitative tests on blood, urine or other body fluid for a drug or drugs of abuse, including illegal drugs and legally available drugs taken other than in appropriate dosage, ingested or absorbed toxic chemicals including any services specified in items 66235, 66237 and 66239, but excluding the surveillance of sports people and athletes for performance improving substances - one or more assays	39.00
66233	Drug assays - including all qualitative and quantitative estimations on blood, urine or other body fluid for a drug or drugs of abuse or a therapeutic drug on a sample collected from a patient participating in a drug abuse treatment programme, or being treated for drug effects or under a court order or parole board supervision, but excluding the detection of nicotine and metabolites in smoking withdrawal programmes - each assay to a maximum of four assays within any twenty eight day period	19.60
66235	Drug assay - quantitative estimation on blood or other body fluid by any method or methods of a drug being used therapeutically for the patient from whom the specimen was taken and not elsewhere specified in the Schedule - one estimation	19.60
66237	Two estimations specified in item 66235	27.30
66239	Three or more estimations specified in item 66235	35.00
66243	Amniotic fluid, spectrophotometric examination of, estimation of lecithin/sphingomyelin ratio, palmitic acid, phosphatidylglycerol or lamellar body phospholipid - one or more examinations or estimations	31.00
66245	Electrophoresis, quantitative or qualitative of serum, urine or other body fluid to demonstrate protein classes or presence and amount of paraprotein, or the isoenzymes of lactate dehydrogenase, alkaline phosphatase and creatine kinase or lipoprotein electrophoresis (only when the Cholesterol is >6.5mmol/l and Triglyceride >3.0 mmol/1 or in the diagnosis of types III and IV hyperlipidaemia), including the preliminary quantitation of total protein, albumin and globulin or of total relevant enzyme activity - one examination to a maximum of two examinations in any twelve month period	29.00
66247	Electrophoresis, quantitative or qualitative of concurrently collected, or collected within a twenty eight day period, serum, urine or other body fluid to demonstrate protein classes or presence and amount of paraprotein, including the preliminary quantitation of total protein, albumin and globulin, or of total relevant enzyme activity - two or more examinations	43.00

SCHEDULE- continued

Item	Pathology service	Fee
$
66251	Alpha-feto protein, Alpha-1 antitrypsin, Alpha-2 macroglobulin, beta-2 microglobulin, C-l esterase inhibitor, Caeruloplasmin, Ferritin (unless specified in item 66263), Haptoglobins, Microalbumin (in proven diabetes mellitus), Prealbumin, Prostate Specific Antigen, Prostatic Acid Phosphotase, Transferrin (unless specified in item 66263), and, in the follow up of proven malignancy, Mucin-like carcinoma associated antigen, CA-125 antigen, CA-19.9 antigen, CA-15.3 antigen, Carcinoembryonic antigen, Mammary serum antigen, Neuron specific enolase, Thyroglobulin - quantitative estimation in serum, urine or other body fluid - one estimation

18.80
66253	Two or more estimations specified in item 66251	35.00
66263	Iron studies consisting of quantitative analysis of iron, transferrin or iron binding capacity and ferritin	37.00
66265	Serum B12, serum folate - one or more estimations within any twenty eight day period	23.50
66267	Red cell folate and serum B12 and, if required, serum folate, to a maximum of three estimations in any twelve month period	42.50
66269	Vitamins, quantitative estimation in blood, urine or other body fluid, by direct or indirect means, of Vitamins A, B1, B2, B3, B6, C, and E - one or more estimations within any six month period	29.00
66271	Vitamin D or D fractions - one or more estimations	29.00
66273	Acetoacetate, alcohol, aminoacids, ammonia, angiotensin converting enzyme, betahydroxybutyrate, cholinesterase, cystine (cysteine), total free fatty acids, histamine, hydroxyindoleacetic acid, hydroxyproline, lactate, neonatal bilirubin (one or more fractions), oxalate, pyruvate, serotonin, xylose, zinc - one quantitative estimation	23.50
66275	Two or more estimations specified in item 66273	36.50
66277	Aluminium, arsenic, beryllium, cadium, copper, chromium, gold, manganese, mercury, nickel, selenium, strontium - in blood, urine or other body fluid or tissue - one or more estimations within any six month period	33.00
66279	Blood lead estimation, other than for occupational health screening purposes, to a maximum of three estimations in any six month period - each estimation	29.00
66281	Porphyrins (one or more fractions), Catecholamines (one or more fractions), Hydroxy Methoxy Mandelic Acid (HMMA), Homovanillic Acid (HVA), Metanephrines, Methoxy Hydroxy Phenylethylene Glycol (MHPG), Phenyl Acetic Acid (PAA) - quantitative including any qualitative estimations - one or more estimations	37.50
66283	Faecal fat, Breath Hydrogen measurements in response to loading with disaccharides - one or more quantitative estimations within any twenty eight day period	37.50

SCHEDULE- continued

Item	Pathology service	Fee
$
66285	Solid tissue or tissues excluding blood elements - assay of one or two enzymes	37.50
66287	Assay of three to five enzymes as specified in item 66285	70.00
66289	Assay of six or more enzymes as specified in item 66285	93.00
66291	Thyroid function tests, including thyrotrophin (TSH) and at least one or more of the following tests - free thyroxine index, free thyroxine, free T3, total T3, thyroxine binding globulin	39.00
66293	Thyrotrophin releasing hormone (TRH) test, including provision and administration of TRH and all necessary estimations of hormones	46.50
66295	Growth hormone suppression by glucose loading, Growth hormone stimulation by exercise, Dexamethasone suppression test, L-Dopa stimulation of growth hormone, where physically performed by a recognised pathologist - one or more procedures	11.00
66297	Gonadotrophin releasing hormone stimulation test, Synacthen stimulation test, Glucagon stimulation test with C-peptide measurement, Pentagastrin stimulation of thyrocalcitonin release, Secretin stimulation of gastrin release, Insulin hypoglycaemia, Arginine infusion, where physically performed by a recognised pathologist - one procedure	37.00
66299	Two or more tests specified in item 66297	59.00
66301	Hormones and hormone binding proteins, quantitative estimation by any method of - ACTH, Aldosterone, Androstenedione, C-peptide, Calcitonin, .Cortisol, Cyclic AMP, DHEAS, 11-Deoxycortisol, Dihydrotestosterone, FSH, Gastrin, Glucagon, Growth hormone, Human Placental Lactogen, Hydroxyprogesterone, Insulin, LH, Oestradiol, Oestriol, Oestrone, Progesterone, Prolactin, PTH, Renin, Sex hormone binding globulin, Somatomedin C(IgF1), free or total Testosterone, TSH (where not requested as part of a thyroid function test), Urine steroid fraction or fractions, Vasoactive intestinal peptide, Vasopressin (anti diuretic hormone) - one estimation	30.00
66303	Two estimations specified in item 66301	40.60
66305	Three estimations specified in item 66301	51.20
66307	Four estimations specified in item 66301	61.80
66309	Five estimations specified in item 66301	72.40
66311	Six or more estimations specified in item 66301	83.00
66315	Hormone receptor assay on proven primary breast or ovarian carcinoma or a metastasis from a breast or ovarian carcinoma or a subsequent lesion in the breast - one or more assays	76.00
66317	HDL cholesterol, or apolipoprotein B/A1 ratio, estimation of, in patients with serum cholesterol >5.5mmol/l or those on prescribed lipid lowering drugs - each estimation to a maximum of four estimations in any twelve month period	11.80

SCHEDULE- continued

Item	Pathology service	Fee
$
66319	Glycosylated haemoglobin only when performed in the management of established diabetes - each estimation to a maximum of four estimations in any twelve month period	15.80
GROUP P3 - MICROBIOLOGY
69201	Microscopic examination of material other than blood, from one or more sites, obtained directly from a patient and excluding material from cultures - wet film, inlcuding differential cell count if performed, examination for dermatophytes or dark ground illumination, or stained preparation or preparations using any relevant stain or stains - one or more examinations	7.00
			69203	Microscopic examination of faeces for parasites using concentration techniques including the use of appropriate stains, to a maximum of three estimations taken on separate days including any services specified in item 69201 - each estimation	11.80
						69205	The cultural examination and microscopical examination when indicated (including the detection of antigens not elsewhere specified in the Schedule) to determine the presence of pathogenic micro-organisms, including fungi but excluding viruses, from nasal swabs, throat swabs, eye swabs and ear swabs, including pathogen identification and antibiotic sensitivity testing, including any services specified in items 69201 - one or more sites	18.40
									69207	Microscopical and cultural examination (including the detection of antigens not elsewhere specified in the Schedule) to determine the presence of pathogenic micro-organisms, including fungi but excluding viruses, from the following sites - skin or other superficial sites, urethra, vagina, cervix or rectum (except for faecal pathogens), or specimens of sputum (except when part of item 69213), including pathogenic identification and antibiotic sensitivity testing, including any services specified in items 69201 and 69205 - one or more examinations on one or more specimens	27.00
												69209	Microscopical and cultural examination (including the detection of antigens not elsewhere specified in the Schedule) of post-operative wounds, aspirations of body cavities, synovial fluid CSF and operative or biopsy specimens for the presence of pathogenic micro-organisms, including fungi but excluding viruses, involving aerobic and anaerobic culture and the use of different culture media and including pathogen identification and antibiotic sensitivity testing, including any services specified in items 69201, 69205 and 69207 - one or more sites	36.50

SCHEDULE- continued

Item	Pathology service	Fee
$
69211	Cultural examination (including the detection of Clostridial toxins or antigens not elsewhere specified in the Schedule) of faeces to determine the presence or absence of faecal pathogens, involving the use of at least two selective or enrichment media as well as culture in at least two different atmospheres and includes pathogen identification and antibiotic sensitivity testing, including any services specified in item 69201, to a maximum of three specimens in any seven day period - each examination	44.50
69213	Microscopy with appropriate stains and cultural examinations of three specimens of sputum, urine or other bodily fluids for mycobacteria and any other bacterial pathogens, including pathogen identification and antibiotic sensitivity testing and including any services specified in item 69201	62.00
69215	Blood culture to determine the presence or absence of pathogenic micro-organisms excluding viruses, including serial cultures and sub-cultures, any relevant cultural methods and any tests necessary to identify any cultured pathogen and necessary antibiotic sensitivity testing - each set of cultures to a maximum of three sets	16.20
69217	Urine examination including serial examination, with cell count, relevant stained preparations, cultur, colony count by any method, identification of any cultured pathogens, antibiotic sensitivity testing when necessary, and with any relevant general examination for pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone or bile salts (Simple culture by dip slide is excluded from this item)	19.00
69219	Direct detection of the antigens of Haemophilus influenzae, Streptococcus pneumoniae, Neisseria meningitidis, Group B streptococcus (in CSF and urine specimens only), RSV, cryptococcal antigens and Varicella zoster or detection of Clostridium difficile toxin except where item 69211 has been performed - one or more estimations	15.60
69221	Direct detection of Chlamydia from clinical material, not cultures -one or more estimations	9.30
69223	Direct detection of Herpes simplex from clinical material, not cultures - one or more estimations	9.30
69225	Investigation for Herpes simplex virus (one or more types) or Chlamydia trachomatis, in material obtained directly from a patient, by one or more cultural methods, including any services specified in items 69221 and 69223	27.00
69227	All microbiological serology during pregnancy, which must include the determination of Rubella immune status, syphilis serology and Hepatitis B surface antigen and including all services in Items 69229, 69243 and 69245, except in the investigation of a clinically apparent intercurrent microbial illness during that pregnancy	27.00

SCHEDULE- continued

Item		Pathology service	Fee
$
69229		Antibodies to microbial or exogenous antigens not elsewhere specified in the Schedule - estimation of one antibody	13.30
69231		Two estimations specified in item 69229	20.30
69233		Three estimations specified in item 69229	27.30
69235		Four estimations specified in item 69229	34.30
69237		Five estimations specified in item 69229	41.30
69239		Six or more estimations specified in item 69229	48.30
69243		Hepatitis B surface antigen test	13.20
69245		Hepatitis B serology to define the immune status of an individual, including at least Hepatitis B surface antibody or Hepatitis B core antibody tests, including services specified in items 69243, 69247 and 69249	17.80
69247		All serological tests performed for the identification of the agent causing acute Hepatitis, which must include Hepatitis B surface antigen, Hepatitis B core antibody and Hepatitis A IgM antibody tests and those services specified in items 69243, 69245 and 69249	35.00
69249		All tests performed in the follow up of a patient with proven Hepatitis B, including Hepatitis B surface antigen and either Hepatitis Be antigen or Hepatitis B surface antibody tests, including services specified in items 69243 and 69245	25.50
69251		Antibiotics or anti-microbial chemo-therapeutic agents, concentration in serum, urine or other body fluid, by direct quantitative measurement of the agent - one or more estimations	23.50
GROUP P4 - IMMUNOLOGY
71001	Examination for, and identification of, a paraprotein (not previously identified), the presence of which is suggested by other tests (eg item 66245, 66247 or 71005), on serum, urine or other body fluid, or examination of CSF for oligoclonal proteins by immunoelectrophoresis or immunofixation - one or more procedures		29.00
71003	Examination for, and identification of, a paraprotein (not previously identified), the presence of which is suggested by other tests (eg item 66245, 66247 or 71005) on serum and urine concurrently collected -two or more procedures		43.00
71005	Immunoglobulins G, A, M or D, quantitative estimation in serum, urine or other body fluid, by any method- estimation of one immunoelobin		14.00
71007	Two estimations specified in item 71005		21.70
71009	Three or more estimations specified in item 71005		29.40
71011	Subclasses of Immunoglobulin G, 1 to 4, estimation where there is a reduced level of clinical significance of either total IgG or IgA - one or more estimations		43.00

SCHEDULE- continued

Item	Pathology service	Fee
$
71013	Immunoglobulin E (total), quantitative estimation by any method or methods, with a maximum of two estimations in any twelve month period	24.50
71015	Specific IgG or IgE antibodies to potential allergens - one or more tests for single or multiple allergens with a maximum of four estimations in any twelve month period	22.50
71017	Antinuclear antibodies, detection in serum or other body fluids, including quantitation if required	23.50
71019	Measurment of DNA binding (by Farr or equivalent assay, but excluding the Crithidia method), performed only where a positive antinuclear antibody titre of 1:40 or greater has been obtained	28.50
71021	Antibodies to extractable nuclear antigens, detection of in serum or other body fluids	19.60
71023	Characterization of antibodies to extractable nuclear antigens, performed only where a positive result is obtained including services specified in item 71021	31.00
71025	Antibodies to tissue antigens which are not elsewhere specified in an item in the Schedule - estimation of one antibody	23.00
71027	Two estimations specified in item 71025	27.00
71029	Three estimations specified in item 71025	31.00
71031	Four or more estimations specified in item 71025	35.00
71033	Rheumatoid factor, detection of by any technique	9.30
71035	Quantitation of Rheumatoid factor where detected, including services specified in item 71033	18.40
71037	Complement - total and components - one quantitative estimation	15.40
71039	Two estimations as specified in item 71037	23.10
71041	Three or more estimations as specified in item 71037	30.80
71043	Leucocyte fractionation as a preliminary to leucocyte marker or leucocyte function tests	29.00
71045	Functional tests for leucocytes, including use of all appropriate techniques (except E. rosette technique or similar) and any test specified in Group P1 - Haematology in the Schedule	48.50
71047	Leucocyte surface marker characterization by immunofluorescence or immunoenzyme techniquesto assess lymphoid populations using a minimum of three monoclonal antibodies, including any services in item 71049 - one or more estimations	62.00
71049	Leucocyte surface marker characterization by immunofluorescence or immunoenzyme techiques in the investigation of a probable haematological malignancy using a minimum of seven monoclonal antibodies, including any services in item 71047 - one or more estimations	148.00
71051	HLA typing comprising A, B, C and DR phenotypes	66.00

SCHEDULE- continued

Item	Pathology service	Fee
$
71053	HLA typing, excluding any services specified in item 71051 - one or more antigens	27.00
71055	Mantoux test	9.30
GROUP P5 - HISTOPATHOLOGY
72801	Histopathology examination of biopsy material including all tissue processing, staining and professional opinion or opinions	75.00
72803	Immediate frozen section diagnosis of biopsy material, including any other histopathology examination	122.00
72805	Immunohistochemical investigation of biopsy material by one or more of immunofluorescent, immunoperoxidase or other labelled antibody techniques including any other histopathology examination	93.00
72807	Electron microscopy of biopsy material including any other histopathology examination	99.00
GROUP P6 - CYTOPATHOLOGY
73043	Cytological examination including serial examinations of smears from skin, nipple discharge, lip, mouth, nose or anus for detection of pre-cancerous or cancerous changes - one or more examinations	14.40
73045	Cytological examination including serial examinations for malignant cells of body fluids, sputum (single specimen), urine (single specimen), washings or brushings not specified in item 73043 and any histopathological service performed on that cytology specimen - one or more examinations	28.00
73047	Cytological examination including examination of a series of three sputum or urine specimens for malignant cells	58.00
73049	Cytological examination of material obtained from a patient by fine needle aspiration of solid tissue or tissues	35.00
73051	Cytological examination of material obtained from a patient by fine needle aspiration of solid tissue or tissues where the aspiration is performed by a recognised pathologist; or where a recognised pathologist attends the aspiration and performs cytological examination during the attendance	66.00
73053	Routine cytological examination of smears from cervix for detection of pre-cancerous or cancerous changes in women with no symptoms, signs or recent history suggestive of cervical neoplasia and smears repeated due to an unsatisfactory routine smear - each examination	12.00

SCHEDULE- continued

Item	Pathology service	Fee
$
73055	Cytological examination of smears from cervix in association with the management of previously detected abnormalities including precancerous or cancerous conditions, or the investigation of women with symptoms, signs or recent history suggestive of cervical neoplasia, not associated with Item 73053 -each examination	12.00
73057	Cytological examination of smears from vagina, not associated with Items 73053 or 73055 - each examination	12.00
GROUP P7 - CYTOGENETICS
73281	Chromosome studies, including preparation, count and karyotyping of one or more of amniotic fluid, bone marrow, skin and any other tissue or fluid excluding blood - one or more estimations	128.00
73283	Chromosome studies, including preparation, count and karyotyping of blood	116.00
73285	Chromosome identification by banding techniques (using fluorescein, Giemsa, or centromere staining or high resolution analysis); or by fragile X-site determination - one or more identifications	99.00
GROUP P8 - INFERTILITY AND PREGNANCY TESTS
73521	Semen examination for presence of spermatozoa or examination of cervical mucus for spermatozoa (Huhner’s test)	6.50
73523	Semen examination, involving measurement of volume, sperm count, motility, examination of stained preparations, morphology, and, if performed, differential count and one or more chemical tests, with a maximum of four examinations in any twelve month period	27.00
73525	Sperm antibodies, sperm penetrating ability - one or more tests	17.40
73527	Chorionic gonadotrophin (beta - HCG), qualitative estimation in serum or urine by one or more methods, including serial dilution if performed, for diagnosis of pregnancy - one or more estimations	9.50
73529	Chorionic gonadotrophin (beta-HCG), qualitative (if performed) and quantitative estimation in serum by one or more methods for diagnosis of hydatidiform mole, HCG - secreting neoplasm, threatened abortion or follow-up of abortion	27.00
GROUP P9 - SIMPLE BASIC PATHOLOGY TESTS
73801	Seminal examination for presence of spermatozoa	6.20

SCHEDULE- continued

Item	Pathology service	Fee
$
73802	Blood count consisting of leucocyte count, erythrocyte sedimentation rate, examination of blood film (including differential leucocyte count) or any or all of haemoglobin estimation, haematocrit estimation or erythrocyte count - one procedure	4.15
73803	Two procedures specified in item 73802	6.20
73804	Three or more procedures specified in item 73802	8.25
73805	Microscopical examination of urine	4.15
73806	Pregnancy test by one or more immunochemical methods	10.15
73807	Microscopical examination of wet film other than urine	6.20
73808	Microscopical examination of gram stained film	7.85
73809	Chemical tests for occult blood in faeces by reagent stick, strip, tablet or similar method

2.10
73810	Microscopical examination screening for fungi in skin, hair or nails -one or more sites	6.20
73811	Mantoux test	10.15
GROUP P10 - PATIENT EPISODE INITIATION
73901	Initiation of a patient episode by collection of specimen for a service specified in item 73053, 73055 or 73057 from a person who is not in a recognised hospital or a prescribed laboratory	7.50
73903	Initiation of a patient episode by collection of specimen for a service specified in item 72801 from a person who is an in-patient of a hospital other than a recognised hospital	13.50
73905	Initiation of a patient episode by collection of specimen for a service specified in item 72801 from a person who is not an in-patient of a private hospital and not a patient of a recognised hospital	7.50
73907	Patient episode initiated by collection of specimen for a service other than a service specified in items 73901, 73903, 73905 and 73801 to 73811 (inclusive) where the specimen is collected in a licensed collection centre other than a temporary licensed collection centre	15.50
73909	Patient episode initiated by collection of specimen for a service other than a service specified in items 73901, 73903, 73905 and 73801 to 73811 (inclusive) where the specimen is collected by an approved pathology practitioner or an employee of an approved pathology authority from a person who is an in-patient of a hospital other than a recognised hospital	15.50

SCHEDULE- continued

Item	Pathology service	Fee
$
73911	Patient episode initiated by collection of specimen for a service other than a service specified in items 73901, 73903, 73905 and 73801 to 73811 (inclusive) where the specimen is collected by an approved pathology practitioner or an employee of an approved pathology authority, from a person in the place where the person was residing or in a nursing home or institution	15.50
73913	Patient episode initiated by collection of specimen for a service other than a service specified in items 73901, 73903, 73905, 73907 and 73801 to 73811 (inclusive) where the specimen is collected from the person by the person	9.50
73915	Patient episode initiated by collection of specimen for a service other than a service specified in items 73901, 73903, 73905 and 73801 to 73811 (inclusive) where the specimen is collected by or on behalf of the treating practitioner	9.50
73917	Patient episode initiated by collection of specimen for a service other than a service specified in items 73901, 73903, 73905 and 73801 to 73811 (inclusive) where the specimen is collected in a temporary licensed collection centre	9.50
GROUP P11 - SPECIMEN REFERRED
73921	Referral of specimen by an approved pathology practitioner of an approved pathology authority to another approved pathology practitioner of another approved pathology authority or to another approved pathology authority	9.50

ABBREVIATIONS

A. ABBREVIATIONS FOR GROUPS OF TESTS

Group	Estimations Included in Group	Abbreviation	Item Numbers
Cardiac Enzymes	Lactate dehydrogenase (LDH) Aspartate aminotransferase (AST) and Creatine kinase (CK)	CE	66205/66206
Coagulation Studies	Prothrombin Time, activated partial thromboplastin time and two or more of the following tests-bleeding time, thrombin clotting time, fibrinogen degradation products, fibrin monomer, D-dimer Factor XIII screening tests.	COAG	65035/65036
Electrolytes	Sodium (NA) Potassium (K) Chloride (CL) and Bicarbonate (HCO3)	E	66207/66208
Lipid Studies	Cholesterol (CHOL) and Triglycerides (TRIG)	FATS	66203/66204
Liver	Alkaline phosphatase (ALP),	LFT	66211/66212
Function	Alanine aminotransferase
Tests	(ALT), Aspartate aminotransferase (AST), Albumin (ALB), Bilirubin (BLL), Gamma glutamyl transpeptidase (GGT), Lactate dehydrogenase (LDH), and Protein (PROT).

A. ABBREVIATIONS FOR GROUPS OF TESTS - continued

Group	Estimations Included in Group	Abbreviation	Item Numbers
Syphilis	Rapid plasma reagin test	STS	69231/69232
Serology	(RPR) or venereal disease research laboratory test (VDRL) and Treponema pallidum haemagglutin test (TPHA) or Fluorescent Treponemal antibody-absorption test (FTA)
Urea,	Urea,	U&E	66205/66206
Electrolytes,	Electrolytes,
Creatine	Creatine

 

B. ABBREVIATIONS FOR INDIVIDUAL TESTS

Approved item name of test in Schedule	Abbreviation	Item Number
Abnormal haemoglobins	AH	65027,65028
Acetoacetate	ACAT	66273,66274
Acetylated Sulphadimidine	ASUL	66235,66236
Adrenocorticotrophic hormone	ACTH	66301,66302
AFB Microscopy and culture of Sputum	AFB	69213,69214
Alanine Aminotransferase	ALT	66201,66202
Albumin	ALB	66201,66202
Alcohol (Ethanol)	ETOH	66273,66274
Aldosterone	ALD	66301,66302
Alkaline Phosphatase	ALP	66201,66202
Phosphatase Isoenzymes	ALPI	66245,66246
Alpha feto protein	AFP	66251,66252
Alpha-1 antitrypsin	A AT	66251,66252
Alpha-2 macroglobulin	AMAC	66251,66252
Aluminium	AL	66277,66278
Amiodarone	AMIO	66235,66236
Amitriptyline	AMIT	66235,66236
Ammonia	NH3	66273,66274
Amniotic Fluid Examination	AFE	66243,66244
Amylase	AMS	66201,66202
Amylobarb	AMYL	66235,66236
Androstenedione	ANDR	66301,66302
Angiotensin converting enzyme	ACE	66273,66274
Antibiotic & antimicrobial chemotherapeutic agents, quantitative assay
	QAA	69251,69252
Antibodies to
Extractable Nuclear Antigens - detection	ENA	71021,71022
Extractable Nuclear Antigens - characterization of antibodies if positive ENA
	ENAP	71023,71024
Nuclear Antigens - detection	ANA	71017,71018
Nuclear Antigens-quantitation & measurement of DNA binding if positive ANA
	ANAP	71019,71020
Tissue Antigens:
Acetylcholine Receptor	ARA	71025,71026
Adrenal cell	ADR	71025,71026
Cardiolipin	ACL	71025,71026
Centromere	ACA	71025,71026
Gastric parietal cell	PCA	71025,71026
Gliadin IgA	GLIA	71025,71026
Glomerular basement membrane	GBA	71025,71026
Insulin Receptor Antibodies	INSA	71025,71026
Intercellular cement substance of skin	ICCS	71025,71026
Jo-1	JO1	71025,71026

 

Approved item name of test in Schedule	Abbreviation	Item Number
Keratin	KERA	71025,71026
Liver/Kidney microsomes	LKA	71025,71026
Mitochondria	MA	71025,71026
Parathyroid	PTHA	71025,71026
PM-1	PM1	71025,71026
Reticulin	RCA	71025,71026
Skeletal muscle	SLA	71025,71026
Skin basement membrane	SKA	71025,71026
Smooth muscle	SMA	71025,71026
SCL 70	SCL	71025,71026
Thyroid Microsomal	TMA	71025,71026
TSH Receptor Antibody test	TSHA	71025,71026
Antibody Testing, Microbial	(see Microbial)
Antigen Testing, Microbial	(see Microbial)
Antithrombin III	ATH	65037,65038
Arginine	ARLN	66297,66298
Arsenic	AS	66277,66278
Aspartate Aminotransferase	AST	66201,66202
Barbitone	BARB	66235,66236
Beryllium	BE	66277,66278
Beta Hydroxybutyrate	BHYB	66273,66274
Beta-2 microglobulin	BMIC	66251,66252
Bicarbonate	HCO3	66201,66202
Bilirubin (all fractions)	BILI	66201,66202
(Neonatal)	BILN	66273,66274
Bleeding Time	BT	65029,65030
Blood Culture	BC	69215,69216
Film	BF	65005,65006
Gases	GAS	66225,66228
Group and blood group antibodies	BGAB	65021,65022
Group Antibodies	BGA	65025,65026
Group Systems	BGS	65019,65020
Grouping-ABO and RH (D antigen)	BG	65017,65018
Bone Marrow Examination - Aspirate	BMEA	65015,65016
- Trephine	BMET	65013,65014
Breath Hydrogen test	BHT	66283,66284
Bromide	BRMD	66235,66236
Butobarb	BUTO	66235,66236
C-1 esterase inhibitor	CEI	66251,66252
C-Peptide	CPEP	66301,66302
C-reative protein	CRP	65001,65002
CA-125 antigen	C125	66251,66252
CA-15.3 antigen	CA15	66251,66252
CA-19.9 antigen	CA19	66251,66252

 

Approved item name of test in Schedule	Abbreviation	Item Number
Cadmium	CP	66277,66278
Caeruloplasmin	CPLS	66251,66252
Calcitonin	CALT	66301,66302
Calcium (total, dialysed or ionized)	CA	66201,66202
Calculus Analysis	CALC	66229,66230
Carbamazepine (Tegretol)	CARB	66235,66236
Carboxyhaemaglobin	COHB	65027,65028
Carcinoembryonic antigen	CEA	66251,66252
Catecholamines	CAT	66281,66282
Chlamydia Investigation by Cultural Methods	CHLC	69225,69226
Chloral Hydrate	CHHY	66235,66236
Chlorazepate	CHZP	66235,66236
Chloride	CL	66201,66202
Chloroquine	CLOQ	66235,66236
Chlorpromazine	CHLO	66235,66236
Cholesterol	CHOL	66201,66202
Cholinesterase	CHSE	66273,66274
Chorionic gonadotrophin for pregnancy diagnosis	HCG	73527,73528
- for diagnosis of specified conditions	HCGD	73529,73530
Chromium	CR	66277,66278
Chromosome indentiflcation by banding technique	CSI	73285,73286
studies	CS	73281,73282
studies of blood	CSB	73283,73284
Cimetidine	CMTD	66235,66236
Clobazam	CLOB	66235,66236
Clonazepam (Rivotril)	CLON	66235,66236
Clostridium difficile	CLDT	69219,69220
Coagulation factors (see individual factors) time	CT	65029,65030
Cold Agglutinins	CAG	65027,65028
Collection of specimen (s) for cytological examination	73053,73055, 73057,73901, 73903,73905, 73907,73909
Compatibility testing	XMAT	65023,65024
Complement Total, C3 or C4	COM	71037,71038
(Other complements must be specified)
Copper	CU	66277,66278
Cortisol	CORT	66301,66302
Creatine Kinase	CK	66201,66202
Kinase Isoenzymes	CKI	66201,66202
Kinase Isoenzymes (electrophoresis)	CKIE	66245,66246
Creatinine	C	66201,66202

 

Approved item name of test in Schedule	Abbreviation	Item Number
Cryofibrinogen	CFIB	66213,66214
Cryoglobulins	CGLB	66213,66214
Cryptococcal antigen	CRYN	69219,69220
CSF antigens
- Haemophilus influenzae	CSFA	69219,69220
- Streptococcus pneumoniae	CSFA	69219,69220
- Neisseria meningitidis	CSFA	69219,69220
- Group B streptococcus	CSFA	69219,69220
Cultural Examination of Faeces	FCS	69211,69212
Cyclic AMP	CAMP	66301,66302
Cyclosporin A	CLSA	66235,66236
Cysteine (see Urine Cystine)	UCYS	66213,66214
Cystine (cysteine)	CYST	66273,66274
Cytology from body fluids, sputum (1 specimen), urine, washings or brushings
	BFCY	73045,73046
- from cervix	CCR	73053,73054,
73055,73056
- from fine needle aspiration of solid tissues	FNCY	73049,73050
- from fine needle aspiration of solid tissues aspiration or attendance by a pathologist
	FNCP	73051,73052
- from skin, nipple discharge, lip, mouth, nose or anus	SMCY	73043,73044
- from vagina	CVO	73057,73058
- from 3 sputum or urine specimens	SPCY	73047,73048
D-dimer test	DD	65029,65030
Dehydroepiandrosterone sulphate	DHEA	66301,66302
Deoxycortisol	DCOR
Desethyl Amiodarone	DEAM	66235,66236
Desipramine	DESI	66235,66236
Dexamethasone	DXST	66295,66296
Suppression test	DEXA	66301,66302
Diazepam	DIAZ	66235,66236
Differential Cell Count	DIFF	65005,65006
Digoxin	DIG	66235,66236
Dihydrotestosterone	DHTS	66301,66302
Diphenylhydantion (Dilantin)	DLL	66235,66236
Direct Coombs test	CMBS	65027,65028
Disopyramide (Rythmodan)	DISO	66235,66236
Doxepin	DOXE	66235,66236
Drug abuse treatment programme assay therapeutic -
	DRGA	66233,66234
(drugs not listed must be written in full)	(see each drug)
or Chemical Assays - Overdose	DRGO	66231,66232
Electron microscopy of biopsy material	EM	72807,72808

 

Approved item name of test in Schedule	Abbreviation	Item Number
Electrophoresis, to demonstrate
- protein classes, or paraprotein	EPP1	66245,66246
- protein classes or presence and amount of paraprotein classes, concurrent collection	EPP2	66247,66248
Elements (see individual elements)
Enzyme assays of solid tissue or tissues	ENZS	66285,66286
Erythrocyte assessment of Haemolysis	ERYH	65009,65010
assessment of Metabolic Enzymes	ERYM	65009,65010
count	RCC	65001,65002
sedimentation rate	ESR	65001,65002
Ethosuximide (Zarontin)	ETHO	66235,66236
Euglobulin clot lysis time	ECLT	65037,65038
Factor II	FII	65045,65046
V	FV	65045,65046
VII	FVII	65045,65046
VIII	VIII	65045,65046
IX	FIX	65045,65046
X	FX	65045,65046
XI	FXI	65045,65046
XII	FXII	65045,65046
XIII	XIII	65045,65046
XIII deficiency test	F13D	65029,65030
Faecal Fat	FFAT	66283,66284
Haemoglobin (chemical test)	FHC	66217,66218
Haemoglobin (immunological test)	FHI	66219,66220
Porphyrins (qualitative test)	FPR	66217,66218
Reducing Substances	FRS	66217,66218
Ferritin (see also Iron Studies)	FERR	66251,66252
Fibrin Monomer	FM	65029,65030
Fibrinogen	FIB	65029,65030
Degradation Products	FDP	65029,65030
Fitzgerald Factor	FGF	65045,65046
Flecainide	FLEC	66235,66236
Fletcher Factor	FF	65045,65046
Follicular Stimulating Hormone	FSH	66301,66302
Fructosamine	FRUC	66201,66202
Full Blood Examination	FBE	65007,65008
Gamma Glutamyl Transpeptidase	GGT	66201,66202
Gastrin	GAST	66301,66302
Globulin	GLOB	66201,66202
Glucagon	GSTC	66297,66298
Glucagon	GLGO	66301,66302
Glucose	GLUC	66201,66202
Tolerance Test	GTT	66201,66202

 

Approved item name of test in Schedule	Abbreviation	Item Number
Glycosylated Haemoglobin (Hb Ale)	GHB	66319,66320
Gold	AU	66277,66278
Gonadotrophin	GRHS	66297,66298
Growth Hormone	GH	66301,66302
Hormone-exercise	GHSE	66295,66296
Hormone-glucose	GHSG	66295,66296
Haematocrit	HCT	65001,65002
Haemoglobin Estimation	HB	65001,65002
Haemoglobinopathy tests	HMGP	65011,65012
Haptoglobins	HGLB	66251,66252
HDL Cholesterol	HDLC	66317,66318
Heparin Cofactor II	HRNC	65037,65038
Estimation	HEPR	65043,65044
Hepatitis Serology
Acute hepatitis	HEP	69247,69248
Follow-up of proven Hepatitis B	HEPB	69249,69250
Hepatitis B Serology to define immune status	HEPI	69245,69246
Hepatitis B surface Antigen HBsAg	HBSA	69243,69244
Herpes simplex Virus Investigation
by Cultural Methods	HSVC	69225,69226
Heterophile Antibodies	IM	65027,65028
HIAA (Hydroxyindoleacetic acid)	HIAA	66273,66274
Histamine	HIAM	66273,66274
Histopathology of biopsy material	HIST	72801,72802
HLA Typing, comprimising A,B,C and DR phenotypes	HLA	71051,71052
Typing, one or more antigens	HLAN	71053,71054
HMMA (Hydroxy Methoxy Mandelic acid -previously known as VMA)	HMMA	66281,66282
Homovanillic acid	HVA	66281,66282
Hormone Receptor Assay	HRA	66315,66316
Ovarian	HRO	66315,66316
Hormones:
Adrenocorticotrophic hormone	ACTH	66301,66302
Aldosterone	ALDS	66301,66302
Androstenedione	ANDR	66301,66302
C-Peptide	CPEP	66301,66302
Calcitonin	CALT	66301,66302
Cortisol	CORT	66301,66302
Cyclic AMP	CAMP	66301,66302
Dehydroepiandrosterone sulphate	DHEA	66301,66302
Dihydrotestosterone	DHTS	66301,66302
Follicular Stimulating Hormone	FSH	66301,66302
Gastrin	GAST	66301,66302

 

Approved item name of test in Schedule	Abbreviation	Item Number
Glucagon	GSTC	66297,66298
Glucagon	GLGO	66301,66302
Gonadotrophin	GRHS	66297,66298
Growth Hormone	GH	66301,66302
Growth Hormone-exercise	GHSE	66297,66298
Growth Hormone-glucose	GHSG	66297,66298
Hormone Receptor Assay	HRA	66315,66316
Human Placental Lactogen	HPL	66301,66302
Hydroxyprogesterone	OHP	66301,66302
Insulin	INS	66301,66302
Insulin	INHY	66297,66298
Luteinizing Hormone	LH	66301,66302
Oestradiol	E2	66301,66302
Oestriol	E3	66301,66302
Oestrone	E1	66301,66302
Parathyroid Hormone	PTH	66301,66302
Pentagastrin	PSTR	66297,66298
Progesterone	PROG	66301,66302
Prolactin	PROL	66301,66302
Renin	REN	66301,66302
Sex Hormone Binding globulin	SHBG	66301,66302
Somatomedin	SOMA	66301,66302
Testosterone	TES	66301,66302
Thyroid stimulating hormone (where not requested as part of TFTs)	TSH	66301,66302
Urine Steroid Fraction or Fractions	USF	66301,66302
Vasoactive Intestinal Peptide	VIP	66301,66302
Vasopressin	ADH	66301,66302
11 Deoxycortisol	DCOR	66301,66302
Huhner’s test	HT	73521,73522
Human placental lactogen	HPL	66301,66302
HVA (Homovanillic acid)	HVA	66281,66282
Hydroxproline	HYDP	66273,66274
Hydroxy Methoxy Mandelic acid
(previously known as VMA)	HMMA	66281,66282
Hydroxychloriquine	HOCQ	66235,66236
Hydroxyindoleacetic acid	HIAA	66273,66274
Hydroxyprogesterone	OHP	66301,66302
Imipramine	IMIP	66235,66236
Immediate frozen section diagnosis of biopsy material	FS	72803,72804
Immunoglobulins £	IGE	71013,71014
G, A, M or D	IG	71005,71006
G, Subclasses 1-4	SIGG	71011,71012

 

Approved item name of test in Schedule	Abbreviation	Item Number
Immunohistochemical investigation of biopsy material	IHIS	72805,72806
Insulin	INHY	66297,66298
Insulin	INS	66301,66302
Intestinal disaccharidases	INTD	66285,66286
Iron	(see Iron Studies)
Iron Studies (Iron, Transferrin and Ferritin)	IS	66263,66264
L-DOPA	GHLD	66295,66296
Lactate	LACT	66273,66274
Dehydrogenase	LDH	66201,66202
Dehydrogenase Isoenzymes	LDI	66245,66246
Lamellar body phospholipid	LBPH	66243,66244
Lead	PB	66279,66280
Lecithin/Sphingomyelin Ratio (Amniotic fluid)	LS	66243,66244
Leucocyte Count	WCC	65001,65002
Fractionation	LF	71043,71044
Functional tests	LFF	71045,71046
Surface markers in investigation of probable haematological malignancy	LSMH	71049,71050
Surface Markers to assess lymphoid populations	LSML	71047,71048
Lignocaine	LIGN	66235,66236
Lipase	LIP	66201,66202
Lithium	LI	66201,66202
Lupus Anticoagulant	LUPA	65037,65038
Luteinizing Hormone	LH	66301,66302
Magnesium	MG	66201,66202
Mammary serum antigen	MSA	66251,66252
Manganese	MN	66277,66278
Mantoux Test	MANT	71055,71056
Melanogen (see Urine Melanin)	UML	66213,66214
Mercury	HG	66277,66278
Metalbumin detection (Schumm’s test)	SCHM	65027,65028
Metanephrines	MNEP	66281,66282
Methadone	MTDN	66235,66236
Methotrexate	MTTA	66235,66236
Methoxy Hydroxy Phenyethylene Glycol	MHPG	66281,66282
Methsuximide	MSUX	66235,66236
Metronidazole	MRDZ	66235,66236
Mexiletine (Mexitil)	MEX	66235,66236
MHPG (Methoxy Hydroxy Phenyethylene Glycol)	MHPG	66281,66282
Microalbumin	MALB	66251,66252
Microbacteria Microscopy and culture of Sputum	AFB	69213,69214

 

Approved item name of test in Schedule	Abbreviation	Item Number
Microbial Antibody Testing
Actinomycetes	ACT	69229,69230
Adenovirus	ADE	69229,69230
Aspergillus	ASP	69229,69230
Avian precipitins (Bird Fancier’s Disease)	APP	69229,69230
Blastomyces	BLM	69229,69230
Bordetella pertussis	BOR	69229,69230
Borrelia berghoffer	BOB	69229,69230
Brucella	BRU	69229,69230
Campylobacter jejuni	CAM	69229,69230
Candida	CAN	69229,69230
Chlamydia	CHL	69229,69230
Coccidioides	CCC	69229,69230
Coxsackie Bl-6	COX	69229,69230
Cryptococcus	CRY	69229,69230
Cytomegalovirus	CMV	69229,69230
Cytomegalovirus serology in pregnancy	CMVP	69227,69228
Dengue	DEN	69229,69230
Diptheria	DIP	69229,69230
Echinococcus	ECC	69229,69230
Echo-coxsakie group	ECH	69229,69230
Entamoeba Histolytica	AMO	69229,69230
Epstein Barr Virus	EBV	69229,69230
Fluorescent Treponemal antibody
- absorption test (FTA-ABS)	FTA	69229,69230
Haemophilus	HUS	69229,69230
Hepatitis delta antibody - Anti-delta	HDA	69229,69230
Histoplasma	HIP	69229,69230
Hydatid	HYD	69229,69230
Influenza A	FLA	69229,69230
Influenza B	FLB	69229,69230
Legionella pneumophila - Serogroup 1	LP1	69229,69230
Legionella pneumophila - Serogroup 2	LP2	69229,69230
Leishmaniasis	LEI	69229,69230
Leptospira	LEP	69229,69230
Listeria	LIS	69229,69230
Measles	MEA	69229,69230
Micropolyspora faeni	MIC	69229,69230
Mumps	MUM	69229,69230
Murray Valley Encephalitis	MVE	69229,69230
Mycoplasma pneumoniae	MYC	69229,69230
Neisseria gonorrhoea	GON	69229,69230
Newcastle Disease	NCD	69229,69230
Parainfluenza 1	PF1	69229,69230

 

Approved item name of test in Schedule	Abbreviation	Item Number
Parainfluenza 2	PF2	69229,69230
Parainfluenza 3	PF3	69229,69230
Paratyphi	PTY	69229,69230
Pertussis	PER	69229,69230
Pneumococcus	PCC	69229,69230
Poliomyelitis	PLO	69229,69230
Proteus OX 19	POX	69229,69230
Proteus OXK	POK	69229,69230
Q fever	QFF	69229,69230
Rapid Plasma Reagin test	RPR	69229,69230
Respiratory Syncytial Virus	RSV	69229,69230
Ross River Virus	RRV	69229,69230
Rubella	RUB	69229,69230
Rubella Serology in Pregnancy	MSP	69227,69228
Salmonella typhi (H)	SAH	69229,69230
Salmonella typhi (0)	SAO	69229,69230
Schistosoma	STO	69229,69230
Streptococcal Serology - Anti-D-NASE B titre	ADNB	69229,69230
Streptococcal Serology-Anti-streptolysin O titre	ASOT	69229,69230
Tetanus	TET	69229,69230
Thermoactinomyces vulgaris	THE	69229,69230
Thermopolyspora	TPS	69229,69230
Toxocara	TOC	69229,69230
Toxoplasma	TOX	69229,69230
Toxoplasma serology in pregnancy	TOXP	69227,69228
TPHA (Treponema pallidum haemagglutin test)	TPHA	69229,69230
Treponema pallidum haemagglutin test	TPHA	69229,69230
Trichonosis	TOS	69229,69230
Typhus, Weil-Felix	TYP	69229,69230
Varicella zoster	VCZ	69229,69230
VDRL (Venereal Disease Research Laboratory)	VDRL	69229,69230
Yersinia enterocolytica	YER	69229,69230
Microbial Antigen Testing
Chlamydia	CHLY	69221,69222
Herpes simplex Virus	HSV	69223,69224
Varicella Zoster	VCZN	69219,69220
Micropolyspora faeni	MIC	69229,69230
Microscopic examination of faeces for parasites	OCP	69203,69204
examination of material other than blood	M	69201,69202

 

Approved item name of test in Schedule	Abbreviation	Item Number
Microscopy and culture of
- material from nose, throat, eye or ear	MCS1	69205,69206
- material from skin, superficial sites, urethra, vagina, cervix or rectum	MCS2	69207,69208
- post-op wounds, aspirations of body cavities, synovial fluid, CSF, op/biopsy specimens	MCS3	69209,69210
- specimens of sputum

MCS2	69207,69208
- specimens of sputum, urine or other body fluids for mycobacteria	AFB	69213,69214
Mucin like carcinoma associated antigen	MCA	66251,66252
N-Acetyl Procainamide	NAPC	66235,66236
N-Desalkyldothiepin	NDOT	66235,66236
N-Desalkyl Clobazam	NDAC	66235,66236
Doxepin	NDAD	66235,66236
Neuron specific enolase	NSEN	66251,66252
Nickel	NI	66277,66278
Nitrazepam	NITR	66235,66236
Nordothiepin	NDIP	66235,66236
Nortriptyline	NORT	66235,66236
Oestradiol	E2	66301,66302
Oestriol	E3	66301,66302
Oestrone	E1	66301,66302
Osmolality, Serum or Urine	OSML	66223,66224
Oxalate	OXAL	66273,66274
Oxazepam	OXAZ	66235,66236
PAA (Phenyl Acetic Acid)	PAA	66281,66282
Palmitic acid in amniotic fluid	PALM	66243,66244
Paracetamol	PARA	66235,66236
Paraprotein Investigation by
- immuno-electrophoresis or immunofixation	PPRO	71001,71002
- on concurrently collected serum or urine	PPSU	71003,71004
Paraquat	PARQ	66235,66236
Parathyroid Hormone	PTH	66301,66302
Partial Thromboplastin Time	PTT	65029,65030
Passovy Factor	PF	65045,65046
Pentabarb	PENT	66235,66236
Pentagastrin	PSTR	66297,66298
Perhexiline	PHEX	66235,66236
pH measurement of body fluids other man urine	PH	66213,66214
Phenobarbitone	PHBA	66235,66236
Phensuximide	PHEN	66235,66236
Phenyl Acetic Acid	PAA	66281,66282
Phenytoin	PHEY	66235,66236

 

Approved item name of test in Schedule	Abbreviation	Item Number
Phosphate	PHOS	66201,66202
Phosphatidylglycerol	PTGL	66243,66244
Plasminogen	PLAS	65037,65038
Platelet Aggregation	PLTG	65041,65042
Count	PLTC	65001,65002
Porphyrins (quantitative test, one or more fractions)	PR	66281,66282
Potassium	K	66201,66202
Prealbumin	PALB	66251,66252
Prednisolone	PRED	66235,66236
Primidone	PRIM	66235,66236
Procainamide	PCAM	66235,66236
Progesterone	PROG	66301,66302
Prolactin	PROL	66301,66302
Prominal	PROM	66235,66236
Propranolol	PPNO	66235,66236
Prostate specific antigen	PSA	66251,66252
Prostatic Acid Phosphatase	ACP	66251,66252
Protein Total	PROT	66201,66202
C	PROC	65037,65038
S	PROS	65037,65038
Quantitative estim. of specific protein
- Alpha feto protein	AFP	66251,66252
- Alpha-1 antitrypsin	AAT	66251,66252
- Alpha-2 macroglobulin	AMAC	66251,66252
- Beta-2 microglobulin	BMIC	66251,66252
- C-l esterase inhibitor	CEI	66251,66252
- Caeruloplasmin	CPLS	66251,66252
- Ferritin (see also Iron Studies)	FERR	66251,66252
- Haptoglobins	HGLB	66251,66252
- Microalbumin	MALB	66251,66252
- Transferrin (see also Iron Studies)	TRAN	66251,66252
Prothrombin Time	PT	65029,65030
Pyruvate	PVTE	66273,66274
Quinalbarb	QUIB	66235,66236
Quinidine	QUIN	66235,66236
Quinine	QNN	66235,66236
Red Cell Folate and Serum B12 and Serum Folat if required
	RCF	66267,66268
Cell Porphyrins - qualitative test	RCP	65027,65028
Renin	REN	66301,66302
Respiratory Syncytial Virus	RSVN	69219,69220
Reticulocyte Count	RETC	65001,65002

 

Approved item name of test in Schedule	Abbreviation	Item Number
Rheumatoid Factor	RF	71033,71034
Factor Quantitation	RFQ	71035,71036
RSV - Respiratory Syncytial Virus	RSVN	69219,69220
Salicylate-Aspirin	SALI	66235,66236
Secretin	SSGR	66297,66298
Selenium	SE	66277,66278
Semen examination	SEE	73523,73524
examination for spermatozoa	SES	73521,73522
Serotonin	5HT	66273,66274
Serum B12	B12	66265,66266
Folate (with B12)	FOL	66265,66266
Folate (with B12 Red Cell Folate)	RCF	66267,66268
Sex Hormone Binding globulin	SHBG	66301,66302
Snake venom	HISS	66231,66232
Sodium	NA	66201,66202
Somatomedin	SOMA	66301,66302
Sotalol	SALL	66235,66236
Specific IgG or IgE antibodies	ALLG	71015,71016
Sperm antibodies	SAB	73525,73526
penetrating ability	SPA	73525,73526
Stellazine	STEL	66235,66236
Strontium	SR	66277,66278
Sulphadimidine	SPDD	66235,66236
Sulthiame (Ospolot)	SUL	66235,66236
Synacthen Stimulation Test	SYNS	66301,66302
Testosterone	TES	66301,66302
Thalassaemia Studies	TS	65011,65012
Theophylline	THEO	66235,66236
Therapeutic Drugs not listed must be written in full	----
Thiopentone	TOPO	66235,66236
Thioridazine	THIO	66235,66236
Thrombin Time	TT	65029,65030
Thyroglobulin	TGL	66251,66252
Thyroid function tests	TFT	66291,66292
stimulating hormone	TSH	66301,66302
stimulating hormone (where not requested as part of TSTs)	TSH	66301,66302
Thyrotrophin Releasing Hormone Test	TRH	66293,66294
Tissue antigens which are not listed must be written in full	----
Tocainide	TOCN	66235,66236
Total free fatty acids	TFFA	66273,66274

 

Approved item name of test in Schedule	Abbreviation	Item Number
Transferrin (see also Iron Studies)	TRAN	66251,66252
Triglycerides	TRIG	66201,66202
Trimipramine	TRIM	66235,66236
TSH (where not requested as part of a thyroid function test)	TSH	66301,66302
Tumour Markers
CA-125 antigen	C125	66251,66252
CA-19.9 antigen	CA19	66251,66252
CA-15.3 antigen	CA15	66251,66252
Carcinoembryonic antigen	CEA	66251,66252
Hormone receptor ovarian	HRO	66315,66316
Mammary serum antigen	MSA	66251,66252
Mucin like carcinoma associated antigen	MCA	66251,66252
Neuron specific enolase	NSEN	66251,66252
Prostate specific antigen	PSA	66251,66252
Prostatic Acid Phosphatase-one or more fractions	ACP	66251,66252
Thyroglobulin	TGL	66251,66252
Urate	URAT	66201,66202
Urea	U	66201,66202
Urine Bilirubin	UBIL	66213,66214
Cysteine (see Urine Cystine)	UCYS	66213,66214
Cystine (Cysteine)	UCYS	66213,66214
Haemoglobin	UHB	66213,66214
Melanin (Melanogen)	UML	66213,66214
Melanogen (see Urine Melanin)	UML	66208,66214
microscopy, culture, identification and sensitivity	UMCS	69217,69218
Myoglobin	UMY	66213,66214
Porphobilinogen	UPG	66213,66214
Porphyrins (qualitative test)	UPR	66213,66214
Steroid Fraction or Fractions	USF	66301,66302
Urobilinogen	UUB	66213,66214
Valproate (Epilim)	VALP	66235,66236
Vancomycin	VAN	66235,66236
Vasoactive Intestinal Peptide	VIP	66301,66302
Vasopressin	ADH	66301,66302
Viscosity of blood or plasma	VISC	65001,65002
Vitamin D	VTTD	66271,66272
Quantitative Estimation of Vitamins
A,B1, B2, B3, B6, C or E	VIT	66269,66270
VMA (see HMMA)
Von Willebrands factor	VWF	65045,65046
Von Willebrands factor antigen	VWA	65045,65046

 

Approved item name of test in Schedule	Abbreviation	Item Number
Warfarin	WFR	66235,66236
Xylose	XYL	66273,66274
Zinc	ZN	66273,66274
11 Deoxycortisol	DCOR	66301,66302

NOTE

1. Notified in the Commonwealth of Australia Gazette o